|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61K 31/4439 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3600311 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18718215.9 |
| Date of filing the European patent application | 2018-03-26 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/052057 |
| Date | 2018-03-26 |
| (87) | Number | WO 2018/178852 |
| Date | 2018-10-04 |
| (30) | Number | Date | Country code |
| 201762477717 P | 2017-03-28 | US |
| (72) |
BECKMANN, Nicolau , CH
BIDINOSTI, Michael , CH
GIORGETTI, Elisa , CH
NASH, Mark , CH
SHIMSHEK, Derya , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | NEW METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
| NEW METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS |